What are the risk factors for developing graft versus host disease in acute myeloid leukemia patients?
Most of the risk factors for somebody developing GvHD come from the prior to transplant and peri-transplant period. So the factors that we consider as transplant docs formulating a transplant are what type of donor to use what type of conditioning to use, what type of GvHD prophylaxis strategy to use.
So I'd like to describe transplant. It's kind of like you're at a restaurant and it's a la carte, right?
You get to pick what you want for your entree. So each part of a transplant is crafted with the recipient in mind.
You want to be able to give them the strongest transplant in terms of being anti leukemic. But reserve whatever you can as far as risk for that graft versus host disease. So pieces and parts of the transplant from who the cells come from, how we collect those cells.
Do we do anything to manipulate those cells before they go back into the patient. And then what medications we actually give to the patient once those cells have been grafted to try to control the environment in that immediately post-transplant period, are the biggest factors that will tell whether somebody is sort of at high, medium or low risk for graft vs host disease.